The child has a high fever and the hospital has no registration. The young mother of Beijing Xiaoyun is in a hurry. Occasionally, she saw a WeChat public platform called “V Doctorâ€, who can make an appointment for a doctor free of charge. Xiao Yun, who was trying to test the attitude, successfully let the child see the doctor.
Ai Media Consulting expects that China Mobile's medical market will reach 7.42 billion yuan in 2016, maintaining a growth of 63.1%. Mobile medical technology has mushroomed in China, and companies in the field of segmentation have gradually emerged. V is one of them.
Dr. V focuses on providing paediatric medical services, and invites the deputy director of the top three or specialist hospitals to provide non-working hours for patients to provide free appointment consultation services.
Such a "precise appointment" model in the view of Dr. Zhu, the co-founder of V, is to increase the efficiency of medical institutions by revitalizing existing resources, especially the incremental time for the pediatric chief doctor to idle.
Zhu Xiang pointed out that the "precise appointment" model is quite mature in the United States, in fact, "pre-diagnosis consultation" played a role.
The so-called "pre-diagnosis consultation" refers to meeting with a doctor before the visit, directly consulting the relevant condition, and going to the doctor under the guidance of the doctor.
"I think that the real demand for doctors and patients is FaceToFace, which is face-to-face consultation and communication." Zhu Xiang told reporters that "direct meeting" is accurate to calculate in minutes, to ensure accuracy.
Every patient and family member can comment on the doctor after seeing the doctor. Other patients can choose a doctor to make an appointment according to the comments. In the words of Zhu Xiang, "just like the public comment." On the other hand, the review data also helps pediatricians to establish their own brands, and can also show which diseases they are good at, how high the cure rate is, and where they need to be strengthened.
The industry believes that from a deeper perspective, V's project model actually improves the doctor-patient relationship, reducing the "information asymmetry" between doctors and patients, and increasing mutual understanding. It affects the ecology between the entire doctor and patient.
Insen has large-scaled hemp plant base and production base in Yunnan Province of China and the CBD products we supply is through natural extraction with continuous and stable supply. The CBD products Lyphar produced include CBD isolate 99.5% and 99% powder(free of THC), CBD water soluble 10% powder, CBD full spectrum 50%~80% oil, Hemp essential oil and Hemp full spectrum oil. For all products, we control heavy metals, pesticide residues and microorganisms conform with CHP, JP, USP standards. Our product quality is guaranteed by professional third-party laboratory test.
Cbd Series,Cbd Isolate,Cbd Oil,Water Soluble Cbd
Hunan Insen Biotech Co., Ltd , https://www.insenhealth.com